T1	Participants 230 254	Eligible patients (1439)
T2	Participants 147 164	low-risk patients
T3	Participants 424 472	Four-year (postnephrectomy) survival percentages
T4	Participants 284 422	stage (I-IV) and histology (favorable [FH] or unfavorable [UH]), and contributed data to survival and relapse-free survival (RFS) analyses
